Table 2.

Clinical features of HNC patients from the clinical trial UPCI #08-013

Patients, n (%)6 (100)
Gender, n (%)
 Male4 (66.6)
 Female2 (33.3)
Age, years; median (range)57.5 (47–74)
T stage, n (%)
 T11 (16.6)
 T21 (16.6)
 T31 (16.6)
 T43 (50)
N stage, n (%)
 N02 (33.3)
 N12 (33.3)
 N22 (33.3)
Tumor site, n (%)
 Oral cavity2 (33.3)
 Tonsil2 (33.3)
 Larynx2 (33.3)
HPV status, n (%)
 Positive2 (33.5)
 Not evaluated4 (66.5)
Response status, n (%)
 Responder3 (50)
 Partial responder1 (16.6)
 Nonresponder1 (16.6)
 Not available1 (16.6)